Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2001
02/08/2001CA2391351A1 Transcription-free selex
02/08/2001CA2391348A1 Enhanced delivery via serpin enzyme complex receptor
02/08/2001CA2390471A1 Enzymes with beta-(1,6)-endoglucanase activity
02/08/2001CA2387655A1 Sentrin-specific human proteases senp1-3
02/08/2001CA2381958A1 Method for amplification of nucleic acids
02/08/2001CA2381945A1 Mammalian adhesion protease peptides
02/08/2001CA2381565A1 Therapeutic compounds comprised of anti-fc receptor binding agents
02/08/2001CA2381556A1 Sink protein
02/08/2001CA2381437A1 G-protein coupled receptor and dna sequences thereof
02/08/2001CA2381254A1 Agrobacterium-mediated plant transformation method
02/08/2001CA2381056A1 Recombinant hsv-1 and live viral vaccines
02/08/2001CA2381004A1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) or its receptor c-met and to integrins
02/08/2001CA2380850A1 Mutant tn5 transposase enzymes and method for their use
02/08/2001CA2380840A1 Vaccine composition
02/08/2001CA2380837A1 High affinity tgf.beta. nucleic acid ligands and inhibitors
02/08/2001CA2380836A1 Nuclease variant and their use in genotyping assays
02/08/2001CA2380831A1 Moraxella catarrhalis antigen basb117
02/08/2001CA2380825A1 Basb116 dna and proteins from moraxella catarrhalis
02/08/2001CA2380822A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis
02/08/2001CA2380819A1 Basb120 polypeptide and polynucleotide from moraxella catarrhalis
02/08/2001CA2380813A1 Human monoclonal antibodies to her2/neu
02/08/2001CA2380803A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis
02/08/2001CA2380799A1 Rescue of mumps virus from cdna
02/08/2001CA2380794A1 Methods and apparatus for template capture and normalization for submicroliter reaction
02/08/2001CA2380787A1 Microencapsulated nitric oxide synthase source
02/08/2001CA2380639A1 Cloning of the <i>streptomyces avermitilis</i> genes for glycosylation of avermectin aglycones
02/08/2001CA2380631A1 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations
02/08/2001CA2380613A1 Production of l-lysine by corynebacterium strain having mutation in ilvbn operon
02/08/2001CA2380573A1 Prolactin-releasing peptide and method for regulating autonomic functions and treating pain
02/08/2001CA2380545A1 Nucleic acid ligands to cd40ligand
02/08/2001CA2380535A1 High affinity vascular endothelial growth factor (vegf) receptor nucleic acid ligands and inhibitors
02/08/2001CA2380518A1 Novel compounds
02/08/2001CA2380515A1 Polypeptides and polynucleotides from moraxella catarrhalis
02/08/2001CA2380514A1 Attenuated influenza virus useful as vaccine
02/08/2001CA2380501A1 Novel compounds
02/08/2001CA2380498A1 Novel compounds
02/08/2001CA2380473A1 Tenascin-c nucleic acid ligands
02/08/2001CA2380472A1 Gene specifically expressed in human fetal cardiac muscle
02/08/2001CA2380379A1 A method for selective electrofusion of at least two fusion partners having cell-like membranes
02/08/2001CA2380354A1 Novel tachykinin peptides, precursor peptides thereof and genes encoding the same
02/08/2001CA2380351A1 Basb126 polypeptide and polynucleotide from moraxella catarrhalis
02/08/2001CA2380320A1 Mutant bacterial strains l-lysine production
02/08/2001CA2380295A1 Moraxella cattarrhalis basb114 antigens and uses thereof
02/08/2001CA2380108A1 Recombinant rsv virus expression systems and vaccines
02/08/2001CA2380018A1 Immunotherapy in hiv infected persons using vaccines after multi-drug treatment
02/08/2001CA2380009A1 Methods of inhibiting osteoclastogenesis
02/08/2001CA2379969A1 Low volume chemical and biochemical reaction system
02/08/2001CA2379963A1 Mammalian cytokines; related reagents
02/08/2001CA2379832A1 Invasive bacteria-based viral vaccines
02/08/2001CA2379828A1 Attachment of oligonucleotides to solid supports through schiff base type linkages for capture and detection of nucleic acids
02/08/2001CA2379819A1 Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo
02/08/2001CA2379813A1 Nucleic acid sequences encoding polyenoic fatty acid isomerase and uses thereof
02/08/2001CA2379360A1 Human g-protein coupled receptor
02/08/2001CA2379163A1 Method for characterizing nucleic acid fragments
02/08/2001CA2378929A1 Serine proteases
02/08/2001CA2378901A1 Method for detecting and classifying nucleic acid hybridization
02/08/2001CA2378441A1 Plant defensin variants with modified systein residues
02/08/2001CA2378432A1 Proteins and peptides
02/08/2001CA2378331A1 Calcium channel transport polynucleotides, polypeptides, and antibodies
02/08/2001CA2378182A1 Compositions and methods for the treatment of tumors
02/08/2001CA2378168A1 Moraxella catarrhalis antigens basb122 and basb124
02/08/2001CA2378016A1 Use of aspergillus sojae as host for recombinant protein production
02/08/2001CA2377064A1 Purine metabolism genes in plants
02/08/2001CA2376929A1 Digital amplification
02/08/2001CA2376489A1 Microarrays and their manufacture
02/08/2001CA2376245A1 Binding moieties for fibrin
02/08/2001CA2374743A1 Human chaperone proteins
02/08/2001CA2344720A1 Nucleic acid constructs for the modification of polyamine levels in plants
02/07/2001EP1074629A1 Sink protein
02/07/2001EP1074628A1 N-Acetylamino acid racemase
02/07/2001EP1074627A2 25-hydroxyvitamin D3-1a-hydroxylase and DNA encoding the hydroxylase
02/07/2001EP1074626A2 Genes for lysine biosynthetic system derived from thermophilic bacteria
02/07/2001EP1074625A2 DNA vaccine against feline immunodeficiency virus
02/07/2001EP1074624A1 Attenuated chicken-pox virus oka strain gene 62 and method for identifying virus strain for attenuated live chicken-pox vaccine by using the gene
02/07/2001EP1074623A1 ABC transporter
02/07/2001EP1074622A1 NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF
02/07/2001EP1074621A1 Human tsc403 gene and human ing1l gene
02/07/2001EP1074620A1 Monomeric protein of the TGF-beta family
02/07/2001EP1074619A2 Promoter for neuropeptide FF and use thereof for therapy and diagnostics
02/07/2001EP1074618A2 Cadherin materials and methods
02/07/2001EP1074617A2 Primers for synthesising full-length cDNA and their use
02/07/2001EP1074613A1 Lentivirus from the group of immunodeficiency viruses from drill apes (Mandrillus leucophaeus) and its use
02/07/2001EP1074563A1 Chimeric polypeptides enhancing dimer formation through electrostatic interactions and disulfide bond, method for production and uses thereof
02/07/2001EP1074562A1 Monoclonal antibody directed against the thrombin-antithrombin III complex and its use in immunoassays
02/07/2001EP1074559A1 Peptide nucleic acids
02/07/2001EP1074266A2 Live attenuated bacteria for use in a vaccine
02/07/2001EP1073905A1 Methods of selecting internalizing antibodies
02/07/2001EP1073904A2 High-density, miniaturized arrays and methods of manufacturing same
02/07/2001EP1073892A1 Automated molecular pathology apparatus having independent slide heaters
02/07/2001EP1073771A1 New method for the selection of clones of an eypression library involving rearraying
02/07/2001EP1073770A2 Novel method for the identification of clones conferring a desired biological property from an expression library
02/07/2001EP1073769A1 Primer extension methods for detecting nucleic acids
02/07/2001EP1073765A2 Gene screening methods and related assays
02/07/2001EP1073763A1 Methods for transducing fusion molecules
02/07/2001EP1073760A1 Adenovirus mutants with deleted protease gene, complementing cell lines and corresponding vectors for gene transfer
02/07/2001EP1073759A1 Recombinant virus expressing foreign dna encoding feline cd80, feline cd28, feline ctla-4 or feline cd86 and uses thereof
02/07/2001EP1073758A1 Retroviral vectors including modified envelope escort proteins
02/07/2001EP1073757A1 Food-grade cloning vector and their use in lactic acid bacteria
02/07/2001EP1073755A2 Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein
02/07/2001EP1073754A2 Mutant proteases having lower allergenic response in humans and methods for constructing, identifying and producing such proteases